Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,444 across all filing types
Latest filing 2002-11-10 Regulatory Filings
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Presentation at AGM 21 pages ?Kb
Regulatory Filings
2002-11-10 English
Results of Annual General Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a communication titled 'Results of Annual General Meeting' dated 11 November 2002. It provides detailed voting results for resolutions passed at the AGM, including vote counts for, against, abstain, and proxy discretion. It also announces a board change with the appointment of an Acting Chairman. The document is short (2281 characters) and focuses on the official results of shareholder votes at the AGM. There is no detailed financial data or full report content, only voting outcomes and a management appointment. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2002-11-10 English
Circ. to Partic. Orgs.- Reorganisation of Capital 1
Share Issue/Capital Change Classification · 95% confidence The document announces a reorganisation of capital for Imugene Limited, specifically a share consolidation. It includes a timetable for the capital reorganisation events and trading details. There is no detailed financial report or analysis, only an announcement of a capital structure change. This fits the definition of a Share Issue/Capital Change announcement rather than a full financial report or other filing types.
2002-11-10 English
APP Vaccine Patent Granted in the USA 3 pages ?Kb
Regulatory Filings
2002-11-06 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.